AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28294694 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous LLLT
Number of subjects: 60
Study 27260639 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast treatment (immobilisation in a below elbow cast for 6 to 10 weeks)
Number of subjects: 438
Study 27260639 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate surgical fixation (using preferred technique and implant)
Number of subjects: 438
Study 27260639 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast treatment
Number of subjects: 438
Study 27260639 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate surgical fixation
Number of subjects: 438
Study 24313610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pericallosal aneurysms
Number of subjects: 250
Study 24313610 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle cerebral artery aneurysms
Number of subjects: 250
Study 24313610 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebral artery aneurysms
Number of subjects: 250
Study 24313610 — intervention group
Group type: COMPARATOR
Intervention: Overall group
Number of subjects: 250
Study 22100058 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day plus ezetimibe 10 mg/day
Number of subjects: 39
Study 22100058 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20 mg/day
Number of subjects: 39
Study 19499765 — intervention group
Group type: EXPERIMENTAL
Intervention: 90:90s cycle time with 1 chamber sleeve (A)
Number of subjects: 57
Study 19499765 — intervention group
Group type: EXPERIMENTAL
Intervention: 90:90s cycle time with 3 chamber sleeve (B)
Number of subjects: 57
Study 19499765 — intervention group
Group type: EXPERIMENTAL
Intervention: 45:15s cycle time with 1 chamber sleeve (A)
Number of subjects: 57
Study 19499765 — intervention group
Group type: EXPERIMENTAL
Intervention: 45:15s cycle time with 3 chamber sleeve (B)
Number of subjects: 57
Study 17956583 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (single intravenous infusion)
Number of subjects: 49
Study 17956583 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral bacille Calmette‐Guérin (BCG) immunotherapy
Number of subjects: 49
Study 17956583 — intervention group
Group type: COMPARATOR
Intervention: Healthy donors (control group)
Number of subjects: 49
Study 15899957 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion during hyperglycemic clamp (7 mm)
Number of subjects: 49
Study 15899957 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP infusion during hyperglycemic clamp (7 mm)
Number of subjects: 49
Study 15899957 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard meal test
Number of subjects: 49
Study 15899957 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting and postprandial plasma GLP-1 and GIP levels
Number of subjects: 49
Study 11531667 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 42
Study 11531667 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 42
Study 9495395 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (4 microg/kg)
Number of subjects: 20
Study 9495395 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 7851072 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight blood pressure control (aim: < 150/85 mmHg)
Number of subjects: 755
Study 7851072 — intervention group
Group type: COMPARATOR
Intervention: Less tight blood pressure control (aim: < 180/105 mmHg)
Number of subjects: 755
Study 7851072 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 755
Study 7851072 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (beta-blocker)
Number of subjects: 755
Study 3256379 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive interview
Number of subjects: 48
Study 3256379 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective interview
Number of subjects: 48
Study 3256379 — intervention group
Group type: COMPARATOR
Intervention: Waiting period (control)
Number of subjects: 48
Study 31843832 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D ultrasound measurements (automated and manual)
Number of subjects: 225
Study 31843832 — intervention group
Group type: EXPERIMENTAL
Intervention: Software for automated measurements
Number of subjects: 225
Study 31843832 — intervention group
Group type: EXPERIMENTAL
Intervention: Automation impact on reproducibility
Number of subjects: 225
Study 29178865 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care interventions
Number of subjects: 15
Study 25427289 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cm H2O of positive end-expiratory pressure (PEEP)
Number of subjects: 47
Study 25427289 — intervention group
Group type: COMPARATOR
Intervention: Zero added PEEP (control group)
Number of subjects: 47
Study 25427289 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory pressure above 15 cm H2O
Number of subjects: 47
Study 23383733 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth plans implemented during antenatal care (ANC)
Number of subjects: 905
Study 23383733 — intervention group
Group type: COMPARATOR
Intervention: Control group (no birth plans)
Number of subjects: 905
Study 22093847 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified cervical plexus block (Group U) with 2% lidocaine and 0.75% ropivacaine
Number of subjects: 110
Study 22093847 — intervention group
Group type: COMPARATOR
Intervention: Traditional one‐point method for blocking cervical plexus (Group C)
Number of subjects: 110
Study 19679444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked polyethylene (CLPE) against zirconia
Number of subjects: 94
Study 19679444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked polyethylene (CLPE) against stainless steel
Number of subjects: 94
Study 19679444 — intervention group
Group type: COMPARATOR
Intervention: Non-cross-linked polyethylene (non-CLPE) against zirconia
Number of subjects: 94
Study 17223419 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprocedural heparin (n = 758; median duration 2 days)
Number of subjects: 976
Study 17223419 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprocedural heparin (n = 758)
Number of subjects: 976
Study 17223419 — intervention group
Group type: COMPARATOR
Intervention: Postprocedural heparin (n = 555)
Number of subjects: 976
Study 15031785 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir combined with ritonavir
Number of subjects: 0
Study 15031785 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir combined with nelfinavir
Number of subjects: 0
Study 15031785 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir with adefovir-containing regimens
Number of subjects: 0
Study 15031785 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir (general)
Number of subjects: 0
Study 11520729 — intervention group
Group type: EXPERIMENTAL
Intervention: noninvasive PSV (n‐PSV)
Number of subjects: 12
Study 11520729 — intervention group
Group type: COMPARATOR
Intervention: invasive pressure support ventilation (i‐PSV)
Number of subjects: 12
Study 9808145 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol (19‐nor‐1alpha,25‐(OH)2D2)
Number of subjects: 400
Study 9808145 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 400
Study 8592662 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose studies of immediate release products
Number of subjects: 0
Study 8592662 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple dose studies of immediate release products
Number of subjects: 0
Study 8592662 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose studies of sustained release products
Number of subjects: 0
Study 8592662 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple dose studies of sustained release products
Number of subjects: 0
Study 8592662 — intervention group
Group type: COMPARATOR
Intervention: Multiple dose studies
Number of subjects: 0
Study 8592662 — intervention group
Group type: COMPARATOR
Intervention: Single dose studies
Number of subjects: 0
Study 2764328 — intervention group
Group type: EXPERIMENTAL
Intervention: PTL airway training protocol (ten-step protocol including proper airway insertion, patient ventilation, and confirmation of tube placement by auscultation)
Number of subjects: 32
Study 2764328 — intervention group
Group type: EXPERIMENTAL
Intervention: PTL airway training protocol
Number of subjects: 32
Study 1136854 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophyllamine
Number of subjects: 11
Study 1136854 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 11
Study 1136854 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophyllamine (as the only active drug)
Number of subjects: 11
Study 1136854 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine followed by Theophyllamine
Number of subjects: 11
Study 1136854 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine followed by Saline
Number of subjects: 11
Study 30907035 — intervention group
Group type: EXPERIMENTAL
Intervention: Neiguan point acupuncture combined with amiodarone therapy
Number of subjects: 85
Study 30907035 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone therapy alone
Number of subjects: 85
Study 28645976 — intervention group
Group type: EXPERIMENTAL
Intervention: Plating
Number of subjects: 0
Study 28645976 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction and casting
Number of subjects: 0
Study 25595565 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 100 mg/d
Number of subjects: 113
Study 25595565 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 113
Study 23926662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (10 x 3 min at 15 degrees C) with mental skills training
Number of subjects: 6
Study 23926662 — intervention group
Group type: COMPARATOR
Intervention: Temperate water immersion (27 degrees C)
Number of subjects: 6
Study 23926662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (10 degrees C) during physiological test
Number of subjects: 6
Study 21277846 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 84
Study 21277846 — intervention group
Group type: COMPARATOR
Intervention: Manual teethbrushing
Number of subjects: 84
Study 21277846 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual brushing combined with chlorhexidine mouth rinse (0.12%)
Number of subjects: 84
Study 18259856 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC: doxorubicin or epirubicin, plus cyclophosphamide) added to ovarian function suppression/ablation (OFS) and 5 years of tamoxifen
Number of subjects: 174
Study 17448650 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg once daily
Number of subjects: 474
Study 17448650 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 200 microg twice daily
Number of subjects: 474
Study 15283939 — intervention group
Group type: EXPERIMENTAL
Intervention: Dydrogesterone (DYD; 10 mg per day)
Number of subjects: 120
Study 15283939 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA; 10 mg per day)
Number of subjects: 120
Study 15283939 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate (NMG; 5 mg per day)
Number of subjects: 120
Study 15283939 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NETA; 10 mg per day)
Number of subjects: 120
Study 15283939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 11694700 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral penicillin V
Number of subjects: 284
Study 11694700 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular benzathine penicillin G (BPG)
Number of subjects: 284
Study 10195515 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40
Study 10195515 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40
Study 10195515 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study 1854694 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical correction of hypermetropia from the age of 6 months
Number of subjects: 0
Study 1854694 — intervention group
Group type: COMPARATOR
Intervention: Consistent wearing of hypermetropic spectacle correction from the age of 6 months
Number of subjects: 0
Study 6869040 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual therapy (n = 12)
Number of subjects: 56
Study 6869040 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group therapy (n = 11)
Number of subjects: 56
Study 6869040 — intervention group
Group type: EXPERIMENTAL
Intervention: Large group therapy (n = 11)
Number of subjects: 56
Study 6869040 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibliotherapy (n = 12)
Number of subjects: 56
Study 6869040 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (n = 10)
Number of subjects: 56
Study 31778430 — intervention group
Group type: EXPERIMENTAL
Intervention: Floseal®
Number of subjects: 90
Study 31778430 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 90
Study 31778430 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 30394194 — intervention group
Group type: EXPERIMENTAL
Intervention: Active interferential current (AIC) before pilates exercises
Number of subjects: 142
Study 30394194 — intervention group
Group type: COMPARATOR
Intervention: Placebo interferential current (PIC) before pilates exercises
Number of subjects: 142
Study 28728602 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted training using the InMotion robotic gym system for 45 min, three times/week for 12 weeks
Number of subjects: 720
Study 28728602 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy for 45 min, three times/week for 12 weeks
Number of subjects: 720
Study 28728602 — intervention group
Group type: COMPARATOR
Intervention: Usual NHS care in accordance with local clinical practice
Number of subjects: 720
Study 28728602 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted training
Number of subjects: 720
Study 28728602 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy
Number of subjects: 720
Study 28728602 — intervention group
Group type: COMPARATOR
Intervention: Usual NHS care
Number of subjects: 720
Study 23107436 — intervention group
Group type: EXPERIMENTAL
Intervention: Health contract intervention for 4 weeks
Number of subjects: 43
Study 23107436 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 43
Study 21231840 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D ultrasound
Number of subjects: 10
Study 21231840 — intervention group
Group type: COMPARATOR
Intervention: 2D ultrasound
Number of subjects: 10
Study 19596158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity‐Modulated Radiotherapy (IMRT)
Number of subjects: 6
Study 19596158 — intervention group
Group type: COMPARATOR
Intervention: Conventional Radiotherapy (CRT)
Number of subjects: 6
Study 19596158 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT fluence films
Number of subjects: 6
Study 19596158 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined fields
Number of subjects: 6
Study 17908472 — intervention group
Group type: EXPERIMENTAL
Intervention: T(3) sympathicotomy
Number of subjects: 163
Study 17908472 — intervention group
Group type: EXPERIMENTAL
Intervention: T(4) sympathicotomy
Number of subjects: 163
Study 17908472 — intervention group
Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 163
Study 15724514 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial depression level at the first interview
Number of subjects: 184
Study 15724514 — intervention group
Group type: EXPERIMENTAL
Intervention: Loneliness level at the second interview
Number of subjects: 184
Study 15724514 — intervention group
Group type: EXPERIMENTAL
Intervention: Loneliness level after bereavement
Number of subjects: 184
Study 15724514 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in loneliness after bereavement
Number of subjects: 184
Study 11455484 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 0
Study 11455484 — intervention group
Group type: COMPARATOR
Intervention: Standard operations
Number of subjects: 0
Study 11455484 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended operations
Number of subjects: 0
Study 11455484 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass or limited operations
Number of subjects: 0
Study 10403069 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10-mg wafer
Number of subjects: 555
Study 10403069 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 5-mg wafer
Number of subjects: 555
Study 10403069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 555
Study 8024907 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% etidocaine 10 ml
Number of subjects: 8
Study 8024907 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution 10 ml
Number of subjects: 8
Study 2593865 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 micrograms oestradiol (E2)
Number of subjects: 20
Study 2593865 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms oestradiol (E2)
Number of subjects: 20
Study 798110 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment (6 mg of stanozolol per day)
Number of subjects: 21
Study 798110 — intervention group
Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 21
Study 31153798 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning classifier using a convolutional neural network
Number of subjects: 2000
Study 30149141 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term abacus-based mental calculation (AMC) training
Number of subjects: 162
Study 30149141 — intervention group
Group type: COMPARATOR
Intervention: Control group (no AMC training)
Number of subjects: 162
Study 28394217 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRET)
Number of subjects: 85
Study 28394217 — intervention group
Group type: COMPARATOR
Intervention: Control Exposure Therapy (CET)
Number of subjects: 85
Study 23517508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin 2850 IU/0.3 ml subcutaneously once a day for 12 months
Number of subjects: 284
Study 23517508 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment alone (control group)
Number of subjects: 284
Study 23517508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin treatment in older patients
Number of subjects: 284
Study 23271189 — intervention group
Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.45 mg
Number of subjects: 507
Study 23271189 — intervention group
Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.625 mg
Number of subjects: 507
Study 23271189 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 507
Study 23271189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study 21471651 — intervention group
Group type: EXPERIMENTAL
Intervention: MET for the GHJ horizontal abductors
Number of subjects: 61
Study 21471651 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study 18164471 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction therapy
Number of subjects: 0
Study 18164471 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical interventions
Number of subjects: 0
Study 16931656 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-dose propofol (Group HiP)
Number of subjects: 54
Study 12949439 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium nitrate supplementation
Number of subjects: 20
Study 12949439 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 10632646 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg once daily, plus clarithromycin 250 mg and metronidazole 400 mg twice daily
Number of subjects: 204
Study 10632646 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg twice daily, plus clarithromycin 250 mg and metronidazole 400 mg twice daily
Number of subjects: 204
Study 10632646 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg once daily
Number of subjects: 204
Study 10632646 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg twice daily
Number of subjects: 204
Study 9212175 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet
Number of subjects: 254
Study 9212175 — intervention group
Group type: COMPARATOR
Intervention: Control (no low fat diet)
Number of subjects: 254
Study 8020032 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (400 mg/die)
Number of subjects: 0
Study 8020032 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (oral, INR 2.0-3.5)
Number of subjects: 0
Study 3313677 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg twice daily)
Number of subjects: 258
Study 3313677 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g four times daily)
Number of subjects: 258
Study 29240518 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 hours of hand-arm bimanual intensive training (HABIT) over 3 weeks (Group 90, n = 9)
Number of subjects: 18
Study 29240518 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 hours of hand-arm bimanual intensive training (HABIT) over 1.5 weeks (Group 2 × 45, n = 9)
Number of subjects: 18
Study 29240518 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 hours of hand-arm bimanual intensive training (HABIT) (additional training for Group 2 × 45)
Number of subjects: 18
Study 27384732 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD)
Number of subjects: 80
Study 27384732 — intervention group
Group type: COMPARATOR
Intervention: Non-closed suction drainage (non-CSD)
Number of subjects: 80
Study 25546465 — intervention group
Group type: COMPARATOR
Intervention: ASA 81 mg once-daily
Number of subjects: 110
Study 25546465 — intervention group
Group type: COMPARATOR
Intervention: ASA 325 mg once-daily
Number of subjects: 110
Study 25546465 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA 81 mg four times daily
Number of subjects: 110
Study 23324310 — intervention group
Group type: EXPERIMENTAL
Intervention: MDA measured in septic rats after intraperitoneal injection of MDR Pseudomonas aeruginosa
Number of subjects: 0
Study 23324310 — intervention group
Group type: EXPERIMENTAL
Intervention: MDA measured in serum of patients with sepsis by MDR Gram-negative bacteria
Number of subjects: 0